Advertisement
The prevalence of autism spectrum disorder has increased significantly during the past 10 to 20 years and will continue to increase among all race and ethnicity groups in the coming years

Autism Rates Up, Particularly Among Minority Children

0
Authors say minority rates passing those of whites and expected to continue
Current evidence does not support routine use of haloperidol or second-generation antipsychotics for prevention or treatment of delirium in hospitalized adults

Evidence Says Antipsychotics Do Not Prevent Delirium in Adults

0
Evidence also refutes routine use of haloperidol, second-generation antipsychotics for tx of delirium
There is a long-term association between adolescent oral contraceptive use and depression risk in adulthood

Adolescent Oral Contraceptive Use Tied to Later Depression Risk

0
Findings show long-term impact, regardless of current oral contraception use in adulthood
People who remain married in older age may have a lower dementia risk

Marriage Associated With Lower Dementia Risk

0
Divorced, widowed, separated men show greater risk for dementia than women in same categories

August 2019 Briefing – Psychiatry

0
Here are what the editors at HealthDay consider to be the most important developments in Psychiatry for August 2019. This roundup includes the latest...
For football players in the National Football League

NFL Seasons of Play, Playing Position Affect Mental Health

0
Seasons of professional play and playing position in NFL linked to cognition-related quality of life
Opioid deaths decreased during January to July 2018

CDC: January to July 2018 Saw Decrease in Opioid Deaths

0
But deaths from illicitly manufactured fentanyl increased during same period
Exposure to opioid maintenance treatment in the womb does not seem to cause additional harm to newborns

Prenatal Exposure to OMT Does Not Worsen Neonatal Outcomes

0
Growth parameters similar to those for newborns of women with opioid use disorders during pregnancy
The number of marijuana growers allowed to produce the drug for U.S. government-approved research will be expanded from one to 34

DEA to Approve Dozens More Growers for Marijuana Research

0
Added sites will provide researchers with greater variety of marijuana to study
Purdue Pharma

OxyContin Maker Offers Up to $12 Billion to Settle Opioid Claims

0
Potential deal has been discussed by lawyers representing Purdue and at least 10 state attorneys general